CG Insider Notice: 202,606 Carlyle Shares via Morgan Stanley ($13.0M)

Rhea-AI Filing Summary

The Carlyle Group Inc. (symbol CG) filed a Form 144 reporting a proposed sale of 202,606 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $13,013,565.73. The shares are listed on NASDAQ and the sale is indicated for 08/12/2025.

The filing lists the lots to be sold as acquired primarily via restricted stock vesting (2015–2024) and founder stock (01/02/2020). The form also shows a related seller, JEFFREY WILLIAM FERGUSON REV TRUST, sold 97,394 shares on 08/11/2025 for $6,074,882.57. Several administrative fields (for example filer CIK and notice date) are not provided in the form content.

Positive

• Proposed sale is routed through a registered broker (Morgan Stanley Smith Barney LLC), indicating an orderly sale process.
• Acquisition history is disclosed showing shares were obtained via restricted stock vesting (2015–2024) and founder stock (01/02/2020).

Negative

• None.

Insights

Securities Analyst

TL;DR Insider-related sale of 202,606 CG shares (~$13.0M) via broker; appears routine under Rule 144 with limited dilution versus outstanding shares.

The filing discloses a proposed sale of 202,606 common shares valued at $13,013,565.73 and reports total shares outstanding of 361,704,907. The proposed sale represents approximately 0.056% of outstanding shares based on those figures. Transactions are reported as distributions from restricted stock vesting and founder stock, and the sale is to be executed through Morgan Stanley Smith Barney LLC. Based on the disclosed amounts, the direct market impact is likely limited.

Corporate Governance Expert

TL;DR Rule 144 disclosure shows scheduled sales from vested awards and a recent trust sale; disclosure is straightforward though some form fields are blank.

The Form 144 lists multiple acquisition lots (2015–2024) identified as restricted stock vesting and a founder stock lot dated 01/02/2020. A trustee-related sale is recorded for 08/11/2025. The presence of a named broker and explicit acquisition lots aligns with standard Rule 144 reporting practices. The filing content provided omits several administrative items such as filer CIK and the notice date, which should be present in a complete filing record.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	202606	13013565.73	361704907	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/01/2019	Restricted stock vesting under a registered plan	Issuer			40404	08/01/2019	Services Rendered
Common	08/01/2016	Restricted stock vesting under a registered plan	Issuer			10036	08/01/2016	Services Rendered
Common	08/01/2017	Restricted stock vesting under a registered plan	Issuer			19543	08/01/2017	Services Rendered
Common	01/02/2020	Founder Stock	Issuer			59482	01/02/2020	Services Rendered
Common	08/03/2015	Restricted stock vesting under a registered plan	Issuer			1519	08/03/2015	Services Rendered
Common	08/01/2018	Restricted stock vesting under a registered plan	Issuer			37764	08/01/2018	Services Rendered
Common	08/01/2024	Restricted stock vesting under a registered plan	Issuer			33858	08/01/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFFREY WILLIAM FERGUSON REV TRUST 1001 Pennsylvania Avenue, NW Washington DC 20004	Common	08/11/2025	97394	6074882.57

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Carlyle's (CG) Form 144 report?

The Form 144 reports a proposed sale of 202,606 common shares valued at $13,013,565.73, scheduled for 08/12/2025 on NASDAQ.

Who is the broker handling the sale in the Form 144?

The broker listed is Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004).

How were the shares being sold acquired?

The shares were recorded as acquired primarily through restricted stock vesting (2015–2024) and one lot of founder stock dated 01/02/2020.

Were any related sales reported in the past three months?

Yes. JEFFREY WILLIAM FERGUSON REV TRUST sold 97,394 shares on 08/11/2025 for $6,074,882.57 as disclosed in the filing.

Are any required form fields missing from the provided Form 144 content?

Yes. The provided content does not include the filer CIK, filer CCC, the name of issuer field within the form tables, and the notice date/signature fields are not populated in the excerpt.